TrumpRx Opens for Business

What It Covers

Trump launches TrumpRx.gov, a federal website directing consumers to discounted prescription drugs through negotiated deals with pharmaceutical companies. The site lists 43 drugs with claimed savings of 700-1600%, but analysis reveals meaningful discounts exist only for weight loss and fertility medications, not the common prescriptions most insured Americans need.

Key Questions Answered

• •Limited drug coverage: TrumpRx.gov features only 43 prescription drugs from thousands available in the market. The site excludes expensive cancer medications and other high-cost treatments that cause the most financial burden for Americans. More drugs may be added over time, but current coverage addresses a tiny fraction of prescription drug needs facing patients and insurance companies today.
• •Insurance beats TrumpRx pricing: Eighty-five percent of Americans with insurance coverage already pay lower copayments (often around $25 monthly) than TrumpRx prices for common medications treating asthma, high cholesterol, and diabetes. Half of the 43 listed drugs have generic versions available at pharmacies that cost less than TrumpRx prices, making the site irrelevant for most insured consumers and many uninsured cash payers.
• •Obesity and fertility drug savings: TrumpRx delivers genuine discounts on GLP-1 weight loss medications like Wegovy, reducing costs from $1,349 to $349 monthly (74-85% savings), and fertility drugs used in IVF treatments, cutting prices from $966 to $168 for certain medications. These categories benefit because consumers already pay out-of-pocket, creating incentive for pharmaceutical companies to offer discounts in exchange for increased customer volume.
• •US drug pricing structure: Americans pay approximately three times more than other wealthy nations for prescription drugs because the US government does not negotiate prices directly with pharmaceutical companies. Other countries leverage their entire patient populations to demand lower prices and will refuse drugs that remain too expensive, while US insurance companies negotiate separately with less leverage and cannot walk away from effective treatments.
• •Misleading discount claims: Trump announced mathematically impossible discounts of 700-1600% at press conferences with pharmaceutical executives, creating unrealistic expectations before the website launch. The site displays inflated original prices compared to actual pharmacy costs, making discounts appear larger than reality. Disclaimers suggest checking insurance coverage first, but consumers with limited time may overpay by assuming TrumpRx offers the best deal without comparison shopping.